Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-Ecalating Neoadjuvant Chemoimmunotherapy in Early Triple-negative BREASt Cancer

NCT07857486 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT07857486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-Ecalating Neoadjuvant Chemoimmunotherapy in Early Triple-negative BREASt Cancer
Lead sponsor
Institut Paoli-Calmettes
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2032
Enrollment
84 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early triple-negative breast cancer